Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT)

CUSIP: 03828A101

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
143,223,667
Total 13F shares
106,044,815
Share change
-8,856,390
Total reported value
$51,845,704
Put/Call ratio
94%
Price per share
$0.49
Number of holders
89
Value change
-$6,334,916
Number of buys
38
Number of sells
70

Quarterly Holders Quick Answers

What is CUSIP 03828A101?
CUSIP 03828A101 identifies APLT - Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) as of Q1 2025

As of 31 Mar 2025, Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 106,044,815 shares. The largest 10 holders included Vestal Point Capital, LP, Propel Bio Management, LLC, T. Rowe Price Investment Management, Inc., BlackRock, Inc., Knoll Capital Management, LLC, VANGUARD GROUP INC, VR ADVISER, LLC, Schonfeld Strategic Advisors LLC, Simplify Asset Management Inc., and DEUTSCHE BANK AG\. This page lists 89 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.